Product Images Memantine Hydrochloride

The text describes a chart or graph showing the mean change from baseline in ADCS-ADL score for patients undergoing 12 weeks of treatment with either placebo or memantine hydrochloride. The chart may also show a clinical decline.*

This is the description of a clinical trial for Alzheimer's disease. The focus is on the change in the ADCS-ADL score for patients given either a placebo or memantine hydrochloride /donepezil over the course of several weeks. The mean change from baseline is represented graphically with error bars given by the standard error of the mean (SEM).*

This appears to be a visual of a graph displaying the mean change from baseline in SIB score over weeks of treatment with placebo, donepezil, and memantine hydrochloride donepezil. The x-axis appears to represent the weeks of treatment and the y-axis appears to represent the change in SIB score. The graph shows that both donepezil and memantine hydrochloride donepezil resulted in an improvement in SIB score compared to placebo. However, without more context and information, it is difficult to provide a more detailed description or analysis.*

This is a description of a drug called "Memantine Hydrochloride USP" with a strength of 10mg per tablet. Each film-coated tablet comes in a package of 60 tablets. There is a pending USP Assay test. The package is child-resistant, and the tablets should be kept in a tightly closed container as described in the USP. The recommended storage temperature is between 15°C to 30°C (59°F to 86°F). The package insert should be consulted for dosing and prescribing information. The drug is marketed by Ajanta Pharma USA Inc, located in Bridgewater, NJ.*

This is a description of a package of film-coated tablets that contain 5mg of Memantine Hydrochloride in each tablet. The tablets come in a child-resistant package with instructions to keep them away from children. The tablets should be stored in a tightly closed container at a controlled room temperature between 15°C to 30°C (59°F to 86°F). There is a pending USP assay test and the package insert should be read for full prescribing information. The tablets are marketed by Ajanta Pharma USA Inc. and made in India.*